SCHEMBL226926

SCHEMBL226926

CCCCC(C)(C)[O]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL227551 0.90
SCHEMBL2351499 0.88 GGPS1 (0.52)
SCHEMBL4641686 0.88 GGPS1 (0.52)
SCHEMBL3623512 0.88 GGPS1 (0.52)
SCHEMBL3618351 0.88 GGPS1 (0.52)
SCHEMBL3622507 0.88 GGPS1 (0.52)
SCHEMBL1930119 0.88 GGPS1 (0.52)
SCHEMBL4647180 0.88 GGPS1 (0.52)
SCHEMBL3610800 0.88 GGPS1 (0.52)
SCHEMBL4641733 0.88 GGPS1 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 698 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11987587-B2 Chiral bisamino-ether compounds, and method of preparation and use thereof UNIV JINAN (CN) 2024-05-21 US claimed
CN-117983302-A Catalyst containing ferrocene PNP ligand for ethylene selective tetramerization and preparation method and application thereof 华东理工大学 2024-05-07 CN claimed
US-20220162219-A1 Chiral Bisamino-Ether Compounds, And Method of Preparation and Use Thereof UNIV JINAN (CN) 2022-05-26 US claimed
WO-2020007017-A1 CHIRAL BISAMINO-ETHER COMPOUNDS, AND METHOD OF PREPARATION AND USE THEREOF JINAN UNIVERSITY (CN) 2020-01-09 WO claimed
EP-2752419-B1 SPIROBENZYLAMINE-PHOSPHINE, PREPARATION METHOD THEREFOR AND USE THEREOF ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2019-01-02 EP claimed
EP-2275398-B1 APPLICATION OF AN IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION OF AN UNSATURATED CARBOXYLIC ACID ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2016-05-04 EP claimed
US-9108995-B2 Spirobenzylamine-phosphine, preparation method therefor and use thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2015-08-18 US claimed
EP-2272853-B1 SPIRO PHOSPHORUS-OXAZOLINE, SYNTHESIS AND USE THEREOF ZHEJIANG JIUZHOU PHARM CO LTD (CN) 2014-08-27 EP claimed
US-20140194638-A1 Spirobenzylamine-Phosphine, Preparation Method Therefor And Use Thereof ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2014-07-10 US claimed
EP-2752419-A1 SPIROBENZYLAMINE-PHOSPHINE, PREPARATION METHOD THEREFOR AND USE THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2014-07-09 EP claimed
US-8450493-B2 Spiro phosphine-oxazoline, preparation method and application thereof Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2013-05-28 US claimed
US-20110118472-A1 Spiro Phosphine-Oxazoline, Preparation Method and Application thereof Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-05-19 US claimed
US-20110092732-A1 APPLICATION OF IRIDIUM COMPLEXES IN ASYMMETRIC CATALYTIC HYDROGENATION OF UNSATURATED CARBOXYLIC ACIDS Zheijiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-04-21 US claimed
EP-2275398-A1 APPLICATION OF THE IRIDIUM COMPLEX IN ASYMMETRIC CATALYTIC HYDROGENATION FOR UNSATURATED CARBOXYLIC ACID Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-19 EP claimed
EP-2272853-A1 SPIRO PHOSPHORUS-OXAZOLINE, SYNTHESIS AND USE THEREOF Zhejiang Jiuzhou Pharmaceutical Co., Ltd. (CN) 2011-01-12 EP claimed
US-7842744-B2 excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound ADEKA CORPORATION (JP) 2010-11-30 US claimed
US-20090258976-A1 excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound NEGISHI YOSHINORI 2009-10-15 US claimed
US-7553892-B2 excellent in ultraviolet absorption capability at 380 nm with little bleed-out; resin and an absorber, which is a tris/2-hydroxyphenyl/ triazine compound ADEKA CORPORATION (JP) 2009-06-30 US claimed
CN-118325041-A Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-07-12 CN disclosed
EP-0162208-A2 Novel N-substituted 3,4-dihydropyrimidine derivatives, processes for preparing them and pharmaceutical compositions SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1985-11-27 EP disclosed